Código QR (código de barras bidimensional)

Cost-Effectiveness Analysis of a Bivalent RSVPreF Vaccine in Japanese Adults Aged 60 Years and Older

Abstract Introduction Respiratory syncytial virus (RSV) is a major cause of acute respiratory illness. A bivalent RSV prefusion F protein-based (RSVpreF) vaccine was approved in Japan to prevent RSV-related diseases in older adults in 2024. This study evaluated the cost-effectiveness of the RSVpreF...

ver descrição completa

Na minha lista:
Principais autores: Kosaku Komiya, Yoko Hirano, Kazumasa Kamei, Asuka Yoshida, Junko Morii, Ryohei Kobayashi, Reiko Sato
Formato: Artigo
Idioma:Inglês
Publicado em: Adis, Springer Healthcare 2025-07-01
coleção:Infectious Diseases and Therapy
Assuntos:
Cost-effectiveness
Japan
Older adults
Respiratory syncytial virus
RSV
RSVpreF
Acesso em linha:https://doi.org/10.1007/s40121-025-01177-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados